Supplementary Figure S3 from Efficacy of a Small-Molecule Inhibitor of Kras&lt;sup&gt;G12D&lt;/sup&gt; in Immunocompetent Models of Pancreatic Cancer

Samantha B. Kemp; Noah Cheng; Nune Markosyan; Rina Sor; Il‐Kyu Kim; Jill Hallin; Jason Shoush; Liz Quinones; Natalie V. Brown; Jared B. Bassett; Nikhil Joshi; Salina Yuan; Molly Smith; William P. Vostrejs; Kia Z. Perez-Vale; Benjamin Kahn; Feiyan Mo; Timothy R. Donahue; Caius G. Radu; Cynthia Clendenin; James G. Christensen; Robert H. Vonderheide; Ben Z. Stanger

doi:10.1158/2159-8290.30849151

Abstract

MRTX1133 reduces metastatic burden in a tail vein model

Related Publications

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis , Michael E. Goldberg , Danielle Greenawalt +66 more

Abstract KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct subgroups o...

2018 Cancer Discovery 1505 citations

Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

Hira Rizvi , Francisco Sánchez-Vega , Konnor La +29 more

Purpose Treatment of advanced non–small-cell lung cancer with immune checkpoint inhibitors (ICIs) is characterized by durable responses and improved survival in a subset of pati...

2018 Journal of Clinical Oncology 1371 citations

Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS -Mutant Cancers

Snjezana Doğan , Ronglai Shen , Daphne Ang +8 more

Abstract Purpose: The molecular epidemiology of most EGFR and KRAS mutations in lung cancer remains unclear. Experimental Design: We genotyped 3,026 lung adenocarcinomas for the...

2012 Clinical Cancer Research 595 citations

The rise of motivational information systems: A review of gamification research

Jonna Koivisto , Juho Hamari

Today, our reality and lives are increasingly game-like, not only because games have become a pervasive part of our lives, but also because activities, systems and serv...

2018 International Journal of Information ... 1477 citations

Completed SDSS-IV extended Baryon Oscillation Spectroscopic Survey: Cosmological implications from two decades of spectroscopic surveys at the Apache Point Observatory

Shadab Alam , M Aubert , S. Àvila +96 more

We present the cosmological implications from final measurements of clustering using galaxies, quasars, and Lyα forests from the completed Sloan Digital Sky Survey (SDSS) lineag...

2021 Physical review. D/Physical review. D. 1231 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

Download PDF (Free) View on DOI.org

Social Impact

Altmetric

Supplementary Figure S3 from Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

CrossRef

Cite This

APA Style

                            
                                    Samantha B. Kemp, 
                                
                                    Noah Cheng, 
                                
                                    Nune Markosyan
                                
                                et al.
                            
                            (2025). 
                            Supplementary Figure S3 from Efficacy of a Small-Molecule Inhibitor of Kras&lt;sup&gt;G12D&lt;/sup&gt; in Immunocompetent Models of Pancreatic Cancer. 
                            
                            .
                            https://doi.org/10.1158/2159-8290.30849151

Identifiers

DOI: 10.1158/2159-8290.30849151

Data Quality

Data completeness: 70%

Supplementary Figure S3 from Efficacy of a Small-Molecule Inhibitor of Kras<sup>G12D</sup> in Immunocompetent Models of Pancreatic Cancer